180 Autoimmune hepatitis has been a product
of evolution both in the science of autoimmunity and the people committed to its study. Its emergence on the global scene reflects this process. The improved tests for viral infection, the diverse battery of available serological assays with diagnostic specificity, and the general awareness of its different presentations have ensured the consideration of autoimmune hepatitis in all patients with acute or chronic liver disease regardless of age, gender, ethnic background, duration or severity of illness, and transplantation status. The simplified diagnostic scoring system of the IAIHG underscores the diagnostic specificity of a few key features, and the litany of exclusion factors that had characterized its early description check details have been largely bypassed.95 Autoimmune hepatitis has acquired an identity that can be recognized www.selleckchem.com/products/MLN-2238.html immediately,
secured by codified diagnostic criteria, quantified by scoring systems, found throughout the world in all age groups, and treated effectively. The disease that had existed previously only by the exclusion of others can now stand almost fully on its own. Autoimmune hepatitis still lacks an etiology, but this deficiency in fact ensures its differentiation from the hereditary, metabolic, virus-related, and drug-induced conditions that resemble it. Its responsiveness to corticosteroid therapy remains its salient feature and the principal reason for its consideration. Few other liver diseases have a therapy that so consistently benefits the patient and rewards the physician. Like any successful clinical investigation, progress depends on
a multitude of contributors www.selleck.co.jp/products/Rapamycin.html who nurture each other and expand global recognition of the disease. Progress is an endless process that must be pursued by relays of newly committed investigators that reflect global rather than institutional alliances. Future advances in autoimmune hepatitis will depend on the strength of this multi-national network. For the clinician nonscientist, collaborators are the true bases for research success, the principal sources of instruction, and the appropriate recipients of undying gratitude (Table 2). See online Supporting Information for reference cites. Additional Supporting Information may be found in the online version of this article. “
“Background and Aim: Gastritis and intestinal metaplasia (IM) have long been known to be risk factors for and precursors of gastric cancer. We aimed to elucidate the association between gastric cancer risk and the distribution of precancerous lesions in the stomach by histological analyses. Methods: We analyzed patients from whom two biopsy specimens (one from the antrum and one from the corpus) were obtained by upper gastrointestinal endoscopy.